caffeine has been researched along with B16 Melanoma in 7 studies
| Excerpt | Relevance | Reference |
|---|---|---|
| "Caffeine treatment showed glutathione depletion and increased lipid peroxidation with higher glutathione S-transferase activity in both B16F10 and B16F1 cell lines." | 1.32 | Potentiation of lipid peroxidation in B16F10 and B16F1 melanoma cells by caffeine, a methylxanthine derivative: relationship to intracellular glutathione. ( Gude, RP; Shukla, V, 2003) |
| "The Caffeine treated metastatic tumour bearing animals significantly (p<0." | 1.31 | Effect of Caffeine, a xanthine derivative, in the inhibition of experimental lung metastasis induced by B16F10 melanoma cells. ( Gude, RP; Menon, LG; Rao, SG, 2001) |
| "Theophylline- and caffeine-treated B16-F10 cells exhibited low adhesion to laminin/collagen type IV and reduced invasion through Matrigel in an in vitro assay." | 1.30 | Inhibition of melanoma pulmonary metastasis by methylxanthines due to decreased invasion and proliferation. ( Abbruzzese, A; Autuori-Pezzoli, V; Beninati, S; Cardinali, M; Kleinman, HK; Lentini, A; Mattioli, P; Nicolini, L; Pietrini, A, 1998) |
| "Adozelesin is a highly potent alkylating agent that undergoes binding in the minor groove of double-stranded DNA (ds-DNA) at A-T-rich sequences followed by covalent bonding with N-3 of adenine in preferred sequences." | 1.29 | Synergistic and additive combinations of several antitumor drugs and other agents with the potent alkylating agent adozelesin. ( Adams, EG; Bhuyan, BK; Folz, BA; Smith, KS, 1995) |
| "When caffeine was added before or simultaneously with cisplatin, there was little growth inhibition." | 1.28 | Growth inhibition and differentiation of murine melanoma B16-BL6 cells caused by the combination of cisplatin and caffeine. ( Sasaki, T; Tanaka, M; Tomita, K; Tsuchiya, H; Ueda, Y; Yasutake, H, 1989) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 2 (28.57) | 18.7374 |
| 1990's | 2 (28.57) | 18.2507 |
| 2000's | 2 (28.57) | 29.6817 |
| 2010's | 1 (14.29) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| He, J | 1 |
| Li, J | 1 |
| Ye, C | 1 |
| Zhou, L | 1 |
| Zhu, J | 1 |
| Wang, J | 1 |
| Mizota, A | 1 |
| Furusawa, Y | 1 |
| Zhou, G | 1 |
| Shukla, V | 1 |
| Gude, RP | 2 |
| Smith, KS | 1 |
| Folz, BA | 1 |
| Adams, EG | 1 |
| Bhuyan, BK | 1 |
| Lentini, A | 1 |
| Kleinman, HK | 1 |
| Mattioli, P | 1 |
| Autuori-Pezzoli, V | 1 |
| Nicolini, L | 1 |
| Pietrini, A | 1 |
| Abbruzzese, A | 1 |
| Cardinali, M | 1 |
| Beninati, S | 1 |
| Menon, LG | 1 |
| Rao, SG | 1 |
| Tsuchiya, H | 2 |
| Tomita, K | 2 |
| Yasutake, H | 2 |
| Ueda, Y | 2 |
| Tanaka, M | 2 |
| Sasaki, T | 2 |
| Sugihara, M | 1 |
7 other studies available for caffeine and B16 Melanoma
| Article | Year |
|---|---|
Cell cycle suspension: a novel process lurking in G₂ arrest.
Topics: Caffeine; Carbon; Cell Division; Cell Line, Tumor; Cell Survival; Choroid Neoplasms; Dose-Response R | 2011 |
Potentiation of lipid peroxidation in B16F10 and B16F1 melanoma cells by caffeine, a methylxanthine derivative: relationship to intracellular glutathione.
Topics: Antineoplastic Agents; Caffeine; Dose-Response Relationship, Drug; Glutathione; Glutathione Transfer | 2003 |
Synergistic and additive combinations of several antitumor drugs and other agents with the potent alkylating agent adozelesin.
Topics: Animals; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Aphidicolin; Azaciti | 1995 |
Inhibition of melanoma pulmonary metastasis by methylxanthines due to decreased invasion and proliferation.
Topics: Animals; Caffeine; Cell Adhesion; Cell Division; Collagen; Laminin; Lung Neoplasms; Male; Melanins; | 1998 |
Effect of Caffeine, a xanthine derivative, in the inhibition of experimental lung metastasis induced by B16F10 melanoma cells.
Topics: Animals; Caffeine; Female; Hydroxyproline; Lung Neoplasms; Male; Melanoma, Experimental; Mice; Mice, | 2001 |
Growth inhibition and differentiation of murine melanoma B16-BL6 cells caused by the combination of cisplatin and caffeine.
Topics: Antineoplastic Combined Chemotherapy Protocols; Caffeine; Cell Survival; Cisplatin; DNA Damage; DNA | 1989 |
[Combined effect of cisplatin and caffeine on murine B16-BL6 melanoma cells].
Topics: Animals; Caffeine; Cell Cycle; Cell Differentiation; Cell Division; Cisplatin; Dendrites; DNA Repair | 1989 |